Evogen
Latest round
- Series B
Last raised
- Feb 2014
Total raised
- $6.3M
Investors
- 2
About Evogen
Evogen, Inc.Founded in 2002 in Lower Gwynedd, US, Evogen, Inc. focuses on precision medicine and pathogen detection technologies.850 mn from L Catterton.Evogen specializes in advanced solutions for Neurology Proteomics and Genomics, focusing on precision medicine and pathogen detection technologies. The company's core offerings include EvoScore, which delivers objective measurements for the rapid diagnosis of neurological diseases, and HyBeacons, an innovative High Definition PCR (HD PCR™) technology designed for accurate pathogen detection across a range of applications, including infectious diseases, food safety, and biodefense. Additionally, Evogen's SpinCon portable air sampler is engineered for the efficient collection of bioaerosols and pathogens, addressing critical health threats. These products are utilized by healthcare providers, research institutions, and various industries globally, with significant market penetration in North America, Europe, and Asia.Evogen's revenue model is primarily driven by B2B transactions, engaging directly with healthcare providers, research labs, and governmental agencies. The company structures its transactions through strategic partnerships, contracts for product supply, and potentially licensing agreements for its technologies, such as HyBeacons and EvoScore. These offerings are sold through various pricing plans tailored to the specific needs of clients, with options ranging from one-time purchases to subscription-based models for ongoing access to diagnostic tools and updates.Evogen plans to expand its market presence by developing new products aimed at improving diagnostic capabilities in neurology and infectious disease detection. The company is targeting additional markets in Europe and Asia by 2025 to enhance its global footprint.
Who invested in Evogen
2 investors across 3 rounds
See all investors in Evogen
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Evogen
Who invested in Evogen?
Evogen has 2 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Evogen raised?
Evogen has raised 3 venture rounds. Sign up free to see how much each round raised and the total.
When did Evogen last raise money?
Evogen's most recent round on record is a Series B, in Feb 2014.
What does Evogen do?
Evogen is a medical devices & equipment company.
Where is Evogen headquartered?
Evogen is headquartered in Lower Gwynedd, US.
Which VCs invest in companies like Evogen?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back medical devices & equipment companies at Evogen's stage. Their profiles are linked below.
VCs backing medical devices & equipment startups at Series B
Raising like Evogen? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.